（代表性5篇）

1. CRISPR/Cas9-mediated gene correction in newborn rabbits with hereditary tyrosinemia type I, Molecular Therapy, 2020 Nov 19;S1525-0016(20)30621-3;
2. Engineered pigs carrying a gain-of-function NLRP3 homozygous mutation can survive to adulthood and accurately recapitulate human systemic spontaneous inflammatory responses; Journal of Immunology; 2020 Nov 1;205(9):2532-2544;
3. Improving Cpf1-mediated base editing system by combining dCas9/ dead sgRNA with human APOBEC3A variants; Journal of Genetics and Genomics, 2020.
4. Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems. Cellular and Molecular Life Sciences, 2018, 75(19): 3593-3607.
5. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs, Protein & cell, 2018, 9(3): 283-297.